欧州のライフサイエンス・分析機器市場調査 : 2030年までの予測

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2023年7月

Europe Life Science & Analytical Instruments Market Research Forecast to 2030
欧州のライフサイエンス・分析機器市場調査 : 2030年までの予測

レポート目次　　お問合せ・ご注文　　価格・納期について

Europe Life Science & Analytical Instruments Market Research Forecast to 2030
Market Overview
The growth of the Europe life science & analytical instruments market is attributed to the rising demand for analytical instruments in different sectors, increasing strategic initiatives in the life science and analytical instruments market, the growing prevalence of Hospital-acquired Infections (HAIs), and untapped emerging economies. However, the dearth of skilled professionals is anticipated to hamper the market growth.
Life science is the scientific study of living organisms, including their physical and chemical structure, function, development, evolution, and ecology. Life science analytical instruments are used in hospitals, diagnostic laboratories, and pharmaceutical companies. Additionally, these instruments can be utilized for a variety of purposes, including evaluating the components, content, and quality of materials used in drug development.
Life science is the scientific study of living organisms, including their physical and chemical structure, function, development, evolution, and ecology. Life science analytical instruments are used in hospitals, diagnostic laboratories, and pharmaceutical companies. Additionally, these instruments can be utilized for a variety of purposes, including evaluating the components, content, and quality of materials used in drug development.
Market Segmentation
Based on the type, the Europe life science & analytical instruments market has been divided into microscopy, chromatography, cell counting, spectroscopy, PCR, electrophoresis, flow cytometry, next-generation sequencing, centrifuge instruments, cryogenic instruments, and others.
Based on application, the Europe life science & analytical instruments market has been categorized into clinical and diagnostics applications, research applications and others.
Based on end user, the Europe life science & analytical instruments market has been categorized into pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, and others.
Regional Analysis
Factors such as a boost in the biopharmaceutical sector in the European region, rising government initiatives to promote research to find a cure to the increasing number of chronic diseases, a growing number of pharmaceutical manufacturers, improving economies, high disposable income per individual, and increased healthcare spending are driving the growth of the market in this region. Furthermore, the growing R&D activities and the developing biopharmaceutical sector are also expected to drive the European market. The availability of high-end technologies in countries like Germany and growing funding from various public as well as private sources to conduct advanced research are fostering market growth. Europe-based companies are also boosting the market with active collaborations and mergers & acquisitions.
Major Players
Thermo Fisher Scientific Inc., Merck KGAA, BD., Agilent Technologies, Inc., and PerkinElmer Inc.

目次

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 12
1.1 OVERVIEW 12
2 MARKET INTRODUCTION 13
2.1 DEFINITION 13
2.2 SCOPE OF THE STUDY 13
2.3 RESEARCH OBJECTIVE 13
2.4 MARKET STRUCTURE 14
2.5 ASSUMPTIONS & LIMITATIONS 14
3 RESEARCH METHODOLOGY 15
3.1 DATA MINING 15
3.2 SECONDARY RESEARCH 16
3.3 PRIMARY RESEARCH 17
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 18
3.5 FORECASTING TECHNIQUES 19
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20
3.6.1 BOTTOM-UP APPROACH 21
3.6.2 TOP-DOWN APPROACH 21
3.7 DATA TRIANGULATION 22
3.8 VALIDATION 22
4 MARKET DYNAMICS 23
4.1 OVERVIEW 23
4.2 DRIVERS 24
4.2.1 RISING DEMAND FOR ANALYTICAL INSTRUMENTS IN DIFFERENT SECTORS 24
4.2.2 INCREASING STRATEGIC INITIATIVES IN THE LIFE SCIENCE AND ANALYTICAL INSTRUMENTS MARKET 24
4.2.3 GROWING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS (HAIS) 25
4.3 RESTRAINTS 26
4.3.1 DEARTH OF SKILLED PROFESSIONALS 26
4.4 OPPORTUNITIES 27
4.4.1 UNTAPPED EMERGING ECONOMIES 27
5 MARKET FACTOR ANALYSIS 28
5.1 VALUE CHAIN ANALYSIS 28
5.1.1 R&D 29
5.1.2 MANUFACTURING 29
5.1.3 DISTRIBUTION & SALES 29
5.1.4 POST-SALES MONITORING 29
5.2 PORTER’S FIVE FORCES MODEL 30
5.2.1 THREAT OF NEW ENTRANTS 30
5.2.2 BARGAINING POWER OF SUPPLIERS 30
5.2.3 THREAT OF SUBSTITUTES 31
5.2.4 BARGAINING POWER OF BUYERS 31
5.2.5 INTENSITY OF RIVALRY 31
5.3 IMPACT OF COVID-19 ON THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 31
5.3.1 IMPACT ON SUPPLY CHAIN 31
5.3.2 IMPACT ON PRODUCTION 32
5.3.3 IMPACT ON MARKET PLAYERS 32
5.4 QUALITATIVE ANALYSIS OF CGT AND RNA TECHNOLOGIES IN GERMANY 32
5.4.1 OVERVIEW 32
5.4.2 INCREASING INVESTMENTS THROUGH PUBLIC AND PRIVATE SECTORS 32
5.4.3 EMERGING CGT AND RNA TECHNOLOGIES 33
6 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE 34
6.1 OVERVIEW 34
6.2 SPECTROSCOPY 35
6.3 CHROMATOGRAPHY 36
6.4 PCR 37
6.5 MICROSCOPY 38
6.6 FLOW CYTOMETRY 39
6.7 NEXT GENERATION SEQUENCING 39
6.8 CENTRIFUGES 40
6.9 ELECTROPHORESIS 41
6.10 CELL COUNTING 41
6.11 CRYOGENIC INSTRUMENTS 42
6.12 OTHERS 43
7 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION 44
7.1 OVERVIEW 44
7.2 RESEARCH APPLICATIONS 45
7.3 CLINICAL & DIAGNOSTIC APPLICATIONS 45
7.4 OTHERS 46
8 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER 47
8.1 OVERVIEW 47
8.2 HOSPITALS AND DIAGNOSTIC LABORATORIES 48
8.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 48
8.4 OTHERS 49
9 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY 51
9.1 EUROPE 51
9.2 GERMANY 54
9.3 FRANCE 56
9.4 UK 57
9.5 ITALY 59
9.6 SWITZERLAND 60
9.7 SPAIN 62
9.8 REST OF EUROPE 63
10 COMPETITIVE LANDSCAPE 65
10.1 OVERVIEW 65
10.2 COMPETITIVE BENCHMARKING 66
10.3 MAJOR GROWTH STRATEGY IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67
10.5 KEY DEVELOPMENT ANALYSIS 68
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 68
10.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL 68
10.6.2 MERGER /ACQUISTION 68
10.7 FINANCIAL MATRIX 69
10.7.1 SALES (USD MILLION), 2021 69
10.7.2 R&D EXPENDITURE (USD MILLION), 2021 69
11 COMPANY PROFILES 70
11.1 THERMO FISHER SCIENTIFIC INC. 70
11.1.1 COMPANY OVERVIEW 70
11.1.2 FINANCIAL OVERVIEW 71
11.1.3 PRODUCTS OFFERED 72
11.1.4 KEY DEVELOPMENTS 72
11.1.5 SWOT ANALYSIS 73
11.1.6 KEY STRATEGIES 73
11.2 AGILENT TECHNOLOGIES INC. 74
11.2.1 COMPANY OVERVIEW 74
11.2.2 FINANCIAL OVERVIEW 75
11.2.3 PRODUCTS OFFERED 76
11.2.4 KEY DEVELOPMENTS 76
11.2.5 KEY STRATEGIES 76
11.3 QIAGEN 77
11.3.1 COMPANY OVERVIEW 77
11.3.2 FINANCIAL OVERVIEW 78
11.3.3 PRODUCTS OFFERED 78
11.3.4 KEY DEVELOPMENTS 79
11.3.5 SWOT ANALYSIS 79
11.3.6 KEY STRATEGIES 79
11.4 PERKINELMER INC. 80
11.4.1 COMPANY OVERVIEWS 80
11.4.2 FINANCIAL OVERVIEW 80
11.4.3 PRODUCTS OFFERED 81
11.4.4 KEY DEVELOPMENTS 81
11.4.5 KEY STRATEGIES 81
11.5 MERCK KGAA 82
11.5.1 COMPANY OVERVIEW 82
11.5.2 FINANCIAL OVERVIEW 83
11.5.3 PRODUCTS OFFERED 83
11.5.4 KEY DEVELOPMENTS 84
11.5.5 SWOT ANALYSIS 85
11.5.6 KEY STRATEGIES 85
11.6 EPPENDORF SE 86
11.6.1 COMPANY OVERVIEWS 86
11.6.2 FINANCIAL OVERVIEW 87
11.6.3 PRODUCTS OFFERED 88
11.6.4 KEY DEVELOPMENTS 88
11.6.5 KEY STRATEGIES 88
11.7 BRUKER 89
11.7.1 COMPANY OVERVIEW 89
11.7.2 FINANCIAL OVERVIEW 90
11.7.3 PRODUCTS OFFERED 91
11.7.4 KEY DEVELOPMENTS 92
11.7.5 SWOT ANALYSIS 92
11.7.6 KEY STRATEGIES 93
11.8 BD. 94
11.8.1 COMPANY OVERVIEW 94
11.8.2 FINANCIAL OVERVIEW 95
11.8.3 PRODUCTS OFFERED 95
11.8.4 KEY DEVELOPMENTS 96
11.8.5 KEY STRATEGIES 96
11.9 BIO-RAD LABORATORIES, INC. 97
11.9.1 COMPANY OVERVIEW 97
11.9.2 FINANCIAL OVERVIEW 98
11.9.3 PRODUCTS OFFERED 98
11.9.4 KEY DEVELOPMENTS 99
11.9.5 KEY STRATEGIES 99
11.10 HITACHI HIGH-TECHNOLOGIES CORPORATION 100
11.10.1 COMPANY OVERVIEW 100
11.10.2 FINANCIAL OVERVIEW 100
11.10.3 PRODUCTS OFFERED 101
11.10.4 KEY DEVELOPMENTS 101
11.10.5 SWOT ANALYSIS 102
11.10.6 KEY STRATEGIES 102
12 APPENDIX 103
12.1 REFERENCES 103
12.2 RELATED REPORTS 103

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 14
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 17
TABLE 3 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2030 (USD MILLION) 35
TABLE 4 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR SPECTROSCOPY, BY COUNTRY, 2018–2030 (USD MILLION) 36
TABLE 5 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CHROMATOGRAPHY, BY COUNTRY, 2018–2030 (USD MILLION) 37
TABLE 6 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR PCR, BY COUNTRY, 2018–2030 (USD MILLION) 38
TABLE 7 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR MICROSCOPY, BY COUNTRY, 2018–2030 (USD MILLION) 38
TABLE 8 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR FLOW CYTOMETRY, BY COUNTRY, 2018–2030 (USD MILLION) 39
TABLE 9 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR NEXT GENERATION SEQUENCING, BY COUNTRY, 2018–2030 (USD MILLION) 40
TABLE 10 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CENTRIFUGES, BY COUNTRY, 2018–2030 (USD MILLION) 40
TABLE 11 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR ELECTROPHORESIS, BY COUNTRY, 2018–2030 (USD MILLION) 41
TABLE 12 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CELL COUNTING, BY COUNTRY, 2018–2030 (USD MILLION) 42
TABLE 13 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CRYOGENIC INSTRUMENTS, BY COUNTRY, 2018–2030 (USD MILLION) 42
TABLE 14 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018–2030 (USD MILLION) 43
TABLE 15 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018–2030 (USD MILLION) 44
TABLE 16 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018–2030 (USD MILLION) 45
TABLE 17 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CLINICAL & DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018–2030 (USD MILLION) 46
TABLE 18 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018–2030 (USD MILLION) 46
TABLE 19 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018–2030 (USD MILLION) 47
TABLE 20 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018–2030 (USD MILLION) 48
TABLE 21 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2030 (USD MILLION) 49
TABLE 22 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018–2030 (USD MILLION) 50
TABLE 23 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2018–2030 (USD MILLION) 52
TABLE 24 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2030 (USD MILLION) 53
TABLE 25 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018–2030 (USD MILLION) 53
TABLE 26 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018–2030 (USD MILLION) 54
TABLE 27 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2030 (USD MILLION) 54
TABLE 28 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018–2030 (USD MILLION) 55
TABLE 29 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018–2030 (USD MILLION) 55
TABLE 30 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2030 (USD MILLION) 56
TABLE 31 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018–2030 (USD MILLION) 56
TABLE 32 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018–2030 (USD MILLION) 57
TABLE 33 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2030 (USD MILLION) 57
TABLE 34 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018–2030 (USD MILLION) 58
TABLE 35 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018–2030 (USD MILLION) 58
TABLE 36 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2030 (USD MILLION) 59
TABLE 37 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018–2030 (USD MILLION) 59
TABLE 38 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018–2030 (USD MILLION) 60
TABLE 39 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2030 (USD MILLION) 60
TABLE 40 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018–2030 (USD MILLION) 61
TABLE 41 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018–2030 (USD MILLION) 61
TABLE 42 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2030 (USD MILLION) 62
TABLE 43 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018–2030 (USD MILLION) 62
TABLE 44 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018–2030 (USD MILLION) 63
TABLE 45 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018–2030 (USD MILLION) 63
TABLE 46 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018–2030 (USD MILLION) 64
TABLE 47 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018–2030 (USD MILLION) 64
TABLE 48 MAJOR PLAYERS IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 65
TABLE 49 MOST ACTIVE PLAYER IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67
TABLE 50 PRODUCT LAUNCH/ PRODUCT APPROVAL 68
TABLE 51 MERGER/ACQUISITION 68
TABLE 52 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 72
TABLE 53 AGILENT TECHNOLOGIES: PRODUCTS OFFERED 76
TABLE 54 QIAGEN: PRODUCTS OFFERED 78
TABLE 55 QIAGEN: KEY DEVELOPMENTS 79
TABLE 56 PERKINELMER INC.: PRODUCTS OFFERED 81
TABLE 57 MERCK KGAA: PRODUCTS OFFERED 83
TABLE 58 MERCK KGAA: KEY DEVELOPMENTS 84
TABLE 59 EPPENDORF SE: PRODUCTS OFFERED 88
TABLE 60 BRUKER: PRODUCTS OFFERED 91
TABLE 61 BRUKER: KEY DEVELOPMENTS 92
TABLE 62 BD.: PRODUCTS OFFERED 95
TABLE 63 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 98
TABLE 64 HITACHI HIGH-TECHNOLOGIES CORPORATION: PRODUCTS OFFERED 101

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 12
FIGURE 2 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 14
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 20
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE EUROPE LIFE SCIENCE & ANALYTICAL INTRUMENTS MARKET 23
FIGURE 5 DRIVER IMPACT ANALYSIS 25
FIGURE 6 RESTRAINT IMPACT ANALYSIS 26
FIGURE 7 VALUE CHAIN ANALYSIS: EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 28
FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 30
FIGURE 9 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2021 & 2030 (USD MILLION) 34
FIGURE 10 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2021 & 2030 (USD MILLION) 44
FIGURE 11 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2021 & 2030 (USD MILLION) 47
FIGURE 12 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2021 & 2030 (USD MILLION) 51
FIGURE 13 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET SHARE (%), BY COUNTRY, 2021 52
FIGURE 14 BENCHMARKING OF MAJOR COMPETITORS 66
FIGURE 15 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67
FIGURE 16 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET: COMPETITIVE LANDSCAPE 68
FIGURE 17 SALES 2021 69
FIGURE 18 R&D EXPENDITURE, 2021 69
FIGURE 19 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 71
FIGURE 20 THERMO FISHER SCIENTIFIC.: SWOT ANALYSIS 73
FIGURE 21 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT 75
FIGURE 22 QIAGEN: FINANCIAL OVERVIEW SNAPSHOT 78
FIGURE 23 QIAGEN: SWOT ANALYSIS 79
FIGURE 24 PERKINELMER INC.: FINANCIAL OVERVIEW SNAPSHOT 80
FIGURE 25 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 83
FIGURE 26 MERCK KGAA: SWOT ANALYSIS 85
FIGURE 27 EPPENDORF SE: FINANCIAL OVERVIEW SNAPSHOT 87
FIGURE 28 BRUKER: FINANCIAL OVERVIEW SNAPSHOT 90
FIGURE 29 BRUKER: SWOT ANALYSIS 92
FIGURE 30 BD.: FINANCIAL OVERVIEW SNAPSHOT 95
FIGURE 31 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 98
FIGURE 32 HITACHI HIGH-TECHNOLOGIES CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 100
FIGURE 33 HITACHI HIGH-TECHNOLOGIES CORPORATION: SWOT ANALYSIS 102